A Modern, Adaptive FDA Should Support Patients’ Rights To Try New Medications

To reduce the FDA’s authority would be unwise. Yet patients with devastating diagnoses should have faster access to experimental drugs.

from Forbes – Tech http://ift.tt/29nf9rp
via IFTTT